PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer

Xiaolong Wei1, William J Kane1, Sara J Adair1

  • 1Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

Biomolecules
|July 29, 2025
PubMed